Form D · Other Health Care

Definitive Biotechnologies LLC

Elkridge, MD · CIK 0001858315

Offering snapshot reported Mar 21, 2024 · SEC filing

Reported sold
$4.31M
Offering amount: $6M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 6, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.16M$4.31MApr 22, 2021: $1,350,000.00Apr 22, 2021Mar 21, 2024: $4,310,000.00Mar 21, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,350,000 → $4,310,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 21, 2024Amendment$4,310,000$2,960,000vs Apr 22, 202116SEC filing
Mar 21, 2024Initial$900,000No comparison3SEC filing
Apr 22, 2021Initial$1,350,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-396701

Source: Form D, filed Mar 21, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Latham Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6810 Deerpath Road, Suite 405
Elkridge, MD, 21075